2023 Form 5500 filing — Krystal Biotech, Inc. Medical Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20250415125937NAL0001430163001) for Krystal Biotech, Inc. Medical Plan, reported by Krystal Biotech, Inc. under EIN 82-1080209 and plan number 501. It reports 164 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20250415125937NAL0001430163001
Filing year
2023
Form type
2
Plan sponsor
Krystal Biotech, Inc.
EIN
82-1080209
Plan number
501
Location
Pittsburgh, PA
Participants
164
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$150,938
Total liabilities (EOY)
$475,906
Net assets (EOY)
-$324,968
Employer contributions
$2,670,179
Participant contributions
$362,212
Total income / additions
$3,034,206
Benefits paid
$2,926,287
Administrative expenses
$214,270
Total expenses
$3,140,557
Net increase / (decrease)
-$106,351
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Highmark WestADMIN$112,687not reported in the loaded dataset
Henderson Brothers, Inc.BROKER$45,120not reported in the loaded dataset
The Benecon Group, LLCBROKER$44,371not reported in the loaded dataset
Connectcare3PATIENT ADVOCATE$12,092not reported in the loaded dataset

Related Form 5500 pages